Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2029

Conditions

Lupus Nephritis

Interventions

BIOLOGICAL

Umbilical cord mesenchymal stem cells

Treatment: G(glucocorticoid) + i.v. uc-MSC (1×106 cells/Kg)

DRUG

Normal saline

Control: G(glucocorticoid) + i.v. Normal saline

All Listed Sponsors

lead

Chinese PLA General Hospital

OTHER

NCT06485648 - Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis | Biotech Hunter | Biotech Hunter